CAM-3001

· MedImmune Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAM-3001, covering 2012-07-20 to 2017-02-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis [Phase 2]